Search Results - "SUBRAMANIAM, SHYAMA"

Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition by Kannan, Anbarasu, Krishnan, Arunkumar, Ali, Mohammed, Subramaniam, Shyama, Halagowder, Devaraj, Sivasithamparam, Niranjali Devaraj

“…Abstract Gastric cancer is the second most fatal common form of cancer. The crosstalk among signalling pathways that results in the acceleration of epithelial…”
Get full text

ACUTE TOXICITY STUDY AND THERAPEUTIC ACTIVITY OF MODIFIED ARJUNARISHTA ON ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTION IN RATS by SANTHOSHKUMAR, B., DIWAKAR, MANICKAM, SUBRAMANIAM, SHYAMA, SUBRAMANIAM, SAMU

“…Objective: Ayurvedic formulation derived phytomedicine could bring a specific remedy against myocardial infarction (MI) without any side effects. Arjunarishta…”
Get full text

BIOCHEMICAL AND HISTOPATHOLOGICAL CHANGES OF TRADITIONAL SIDDHA FORMULATION ON CCL4 INDUCED LIVER FIBROSIS IN RATS by Manickam, Diwakar, Ramamoorthy, Sri Kamatchi Priya, Kumar, B. Santhosh, Subramaniam, Samu, Subramaniam, Shyama

“…ABSTRACTObjective:The main objective of this study is to evaluate therapeutic activity of traditional siddha formulation on CCl4 induced liver fibrosis in…”
Get full text

Alterations in erythrocyte membrane structure of breast cancer patients treated with CMF--a lipid profile by Subramaniam, S, Subramaniam, S, Jagadeesan, M, Devi, C S

“…Most of the breast cancer patients are treated with CMF which is a combination of three anticancer agents namely cyclophosphamide, methotrexate and…”
Get more information

Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients by Subramaniam, S, Subramaniam, S, Shyamala Devi, C S

“…Most of breast cancer patients are treated with CMF, which is a combination of three anticancer agents, cyclophosphamide, methotrexate and 5-fluorouracil…”
Get more information